{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Indiana",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "80646",
      "recalling_firm": "RemedyRepack Inc.",
      "address_1": "625 Kolter Dr Ste 4",
      "address_2": "N/A",
      "postal_code": "15701-3571",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to 3 medical facilities in Florida.",
      "recall_number": "D-1020-2018",
      "product_description": "Valsartan/HCTZ 160 mg/12.5 mg tablet, 90-count bottle, Rx only, RemedyRepack, 625 Kolter Drive, Suite 4, Indiana, PA 15701",
      "product_quantity": "4 HDPE 90-count bottles (360 tablets)",
      "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.",
      "recall_initiation_date": "20180717",
      "center_classification_date": "20180731",
      "termination_date": "20181017",
      "report_date": "20180808",
      "code_info": "Lot # B0318652-070617; Exp. 07/18"
    }
  ]
}